Skip to content

Artivion AORT Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Abbott logo
AbbottABT
$116M-59.6%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$2.95M+125%
Medtronic logo
MedtronicMDT
$97M-10.2%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$2.78M-78.9%
Globus Medical logo
Globus MedicalGMED
$25.96M+131%
BioLife Solutions logo
BioLife SolutionsBLFS
$190K

Other financials

Income statement

See full
Revenue$116.3M+17.5%
Gross profit$75.4M+18.7%
Operating income$5.8M+170%
Net income$1.4M+381%
EPS (diluted)$0.03+400%

Balance sheet

See full
Cash & equivalents$55.8M+47.9%
Total debt$258.2M-28.8%
Total equity$450.5M+53.1%
Total assets$883.2M+11.6%

Cash flow

See full
Operating cash flow$1.2M+107%
CapEx$8.0M+120%
Free cash flow-$6.8M+66.7%

Valuation

See full
Market cap$1.07B-22.7%
Enterprise value$1.27B-25.5%
P/E91.5×
P/S2.3×-1.2×

Profitability

See full
Gross margin64.6%+0.6pp
Operating margin8.2%+4.1pp
Net margin2.5%+1.5pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity3.1%+1.8pp
Debt / equity0.6×-0.7×
Current ratio3.9×-1.7×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artivion's stock issuance proceeds?
Artivion (AORT) reported stock issuance proceeds of $1.25M in Q1 2026.
How has Artivion's stock issuance proceeds changed year-over-year?
Artivion's stock issuance proceeds decreased by 70.1% year-over-year, from $4.18M to $1.25M.
What is the long-term trend for Artivion's stock issuance proceeds?
Over 4 years (2021 to 2025), Artivion's stock issuance proceeds has grown at a 36.6% compound annual growth rate (CAGR), from $3.76M to $13.07M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.